Evrenzo (roxadustat) - Kyntra Bio
Phosphate Binder Selection, Dosing Interval Adherence, and Suboptimal Anemia Control in Maintenance Hemodialysis Patients on Roxadustat During the Volume-Based Procurement Transition Period: A Case-Control Study (ChiCTR) - Sep 16, 2026 - P=N/A | N=50 | Not yet recruiting | Sponsor: Mindong Hospital of Ningde City; Mindong Hospital of Ningde City 
New trial • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease
https://www.chictr.org.cn/showproj.html?proj=334504
 
Sep 16, 2026
 
Prev Next